In 2018, more than four decades later, the federal government finally acted. In the face of continuing opposition about the ...
News-Medical.Net on MSN
Alcohol-free drinks may reduce harm, if marketing loopholes stop
By Vijay Kumar Malesu As alcohol-free drinks surge in popularity, a new analysis in BMJ warns that without strong regulation ...
Tirzepatide and semaglutide would have to drop their current net prices by 30.5% and 81.9%, respectively, to be cost-effective. Over a lifetime of use, tirzepatide could avert 45,609 obesity cases, 20 ...
Introduction Integrating smoking cessation supports into lung cancer screening can improve abstinence rates. However, healthcare decision-makers need evidence of cost-effectiveness to understand the ...
Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle ...
A stimulant drug used to treat ADHD has become the fastest-growing script on the Pharmaceutical Benefits Scheme, prompting concerns that a trend of “diagnosis on demand” is driving widespread ...
Aon plc (NYSE: AON), a leading global professional services firm, today released updated findings from its multi-year study ...
Global Bioprocess Containers Market OverviewThe global bioprocess containers market is projected to register robust growth, expanding at a CAGR of approximately 28% through 2029. This strong growth ...
A consumer pricing framework for 'Cheapest Compounded Semaglutide,' 'Cheapest Compounded Semaglutide Online,' and 'Cheapest ...
Artificial Intelligence, commonly known as AI, has quietly moved from the pages of science fiction into our everyday lives .
Explore the impact of drug discovery automation in 2026, addressing complexity and improving decision-making across ...
Topiramate Drugs Market Topiramate Drugs Market Dublin, Jan. 16, 2026 (GLOBE NEWSWIRE) -- The "Topiramate Drugs Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results